Adenocarcinoma Of Esophagus Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

DBCOND0067383 (Adenocarcinoma Of Esophagus)Recruiting2 IdentifierTitlePurposeDrugs
NCT04089904Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal AdenocarcinomaTreatment
NCT02998268Study of Pembrolizumab in Locally Advanced Esophageal AdenocarcinomaTreatment